Cargando…

Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice

BACKGROUND: In the present study, the poncirin which is flavonoid-7-o-glycosides (isolated from the Poncirus trifoliata) in nature was evaluated against the Carbon tetra chloride (CCL4)-induced liver injury. The poncirin have been reported for various anti-inflammatory, analgesic activity etc. Based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Hadayat, Khan, Ashrafullah, Baig, Muhammad Waleed, Ullah, Naseem, Ahmed, Naveed, Tipu, Muhammad Khalid, Ali, Hussain, Khan, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168870/
https://www.ncbi.nlm.nih.gov/pubmed/32307011
http://dx.doi.org/10.1186/s12906-020-02906-7
_version_ 1783523731457441792
author Ullah, Hadayat
Khan, Ashrafullah
Baig, Muhammad Waleed
Ullah, Naseem
Ahmed, Naveed
Tipu, Muhammad Khalid
Ali, Hussain
Khan, Salman
author_facet Ullah, Hadayat
Khan, Ashrafullah
Baig, Muhammad Waleed
Ullah, Naseem
Ahmed, Naveed
Tipu, Muhammad Khalid
Ali, Hussain
Khan, Salman
author_sort Ullah, Hadayat
collection PubMed
description BACKGROUND: In the present study, the poncirin which is flavonoid-7-o-glycosides (isolated from the Poncirus trifoliata) in nature was evaluated against the Carbon tetra chloride (CCL4)-induced liver injury. The poncirin have been reported for various anti-inflammatory, analgesic activity etc. Based on the previous studies it was anticipated that the poncirin will ameliorate CCL4-induced liver injury. METHODS: The CCL4-induced acute and chronic liver injury model (albino BALB/c mice) was used. Following the induction of the liver injury various parameters such as food and water intake, body weight and weight to dry ratio changes were assessed. Furthermore, various hematological, biochemical parameters and histological studies such as hemotoxylin and eosin (H and E) staining were performed. The poncirin treatment was also evaluated against the pro-inflammatory cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) using enzyme link immunosorbant assay (ELISA). The Swiss Target prediction software was used to investigate interaction of the poncirin on the various hepatic enzymes. RESULTS: The poncirin treatment markedly improved the behavioral parameters such as food and water intake. The liver weight variation was attenuated and total body was improved markedly. The hematological and biochemical parameters were significantly improved compared to the CCL4 treated groups. The anti-oxidants were induced, while oxidative stress markers were reduced promisingly. The H and E staining showed that poncirin treatment significantly improved the histology of liver compared to the CCL4 treated group. Furthermore, the poncirin treatment also evidently decreased the inflammatory mediators. CONCLUSIONS: The poncirin treatment showed marked improvement in behavioral, biochemical and histological parameters following CCL4-induced liver injury. Additionally, the poncirin treatment also markedly improved the antioxidant enzymes, attenuated the oxidative stress markers and inflammatory cytokines.
format Online
Article
Text
id pubmed-7168870
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71688702020-04-24 Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice Ullah, Hadayat Khan, Ashrafullah Baig, Muhammad Waleed Ullah, Naseem Ahmed, Naveed Tipu, Muhammad Khalid Ali, Hussain Khan, Salman BMC Complement Med Ther Research Article BACKGROUND: In the present study, the poncirin which is flavonoid-7-o-glycosides (isolated from the Poncirus trifoliata) in nature was evaluated against the Carbon tetra chloride (CCL4)-induced liver injury. The poncirin have been reported for various anti-inflammatory, analgesic activity etc. Based on the previous studies it was anticipated that the poncirin will ameliorate CCL4-induced liver injury. METHODS: The CCL4-induced acute and chronic liver injury model (albino BALB/c mice) was used. Following the induction of the liver injury various parameters such as food and water intake, body weight and weight to dry ratio changes were assessed. Furthermore, various hematological, biochemical parameters and histological studies such as hemotoxylin and eosin (H and E) staining were performed. The poncirin treatment was also evaluated against the pro-inflammatory cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) using enzyme link immunosorbant assay (ELISA). The Swiss Target prediction software was used to investigate interaction of the poncirin on the various hepatic enzymes. RESULTS: The poncirin treatment markedly improved the behavioral parameters such as food and water intake. The liver weight variation was attenuated and total body was improved markedly. The hematological and biochemical parameters were significantly improved compared to the CCL4 treated groups. The anti-oxidants were induced, while oxidative stress markers were reduced promisingly. The H and E staining showed that poncirin treatment significantly improved the histology of liver compared to the CCL4 treated group. Furthermore, the poncirin treatment also evidently decreased the inflammatory mediators. CONCLUSIONS: The poncirin treatment showed marked improvement in behavioral, biochemical and histological parameters following CCL4-induced liver injury. Additionally, the poncirin treatment also markedly improved the antioxidant enzymes, attenuated the oxidative stress markers and inflammatory cytokines. BioMed Central 2020-04-19 /pmc/articles/PMC7168870/ /pubmed/32307011 http://dx.doi.org/10.1186/s12906-020-02906-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ullah, Hadayat
Khan, Ashrafullah
Baig, Muhammad Waleed
Ullah, Naseem
Ahmed, Naveed
Tipu, Muhammad Khalid
Ali, Hussain
Khan, Salman
Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title_full Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title_fullStr Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title_full_unstemmed Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title_short Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
title_sort poncirin attenuates ccl4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168870/
https://www.ncbi.nlm.nih.gov/pubmed/32307011
http://dx.doi.org/10.1186/s12906-020-02906-7
work_keys_str_mv AT ullahhadayat poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT khanashrafullah poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT baigmuhammadwaleed poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT ullahnaseem poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT ahmednaveed poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT tipumuhammadkhalid poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT alihussain poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice
AT khansalman poncirinattenuatesccl4inducedliverinjurythroughinhibitionofoxidativestressandinflammatorycytokinesinmice